Zoonotic Influenza A(H7N9) Evolution and Vaccine Development

Size: px
Start display at page:

Download "Zoonotic Influenza A(H7N9) Evolution and Vaccine Development"

Transcription

1 Influenza Zoonotic Influenza A(H7N9) Evolution and Vaccine Development David E. Wentworth Chief, Virology Surveillance and Diagnosis Influenza Division, NCIRD Centers for Disease Control and Prevention Atlanta, GA USA

2 Significant Increase in A(H7N9) Infections (W5) Influenza Division Wave 5 N=766 N=320 N=135 N=224 N=119 Epidemic Curve of Confirmed Avian Influenza A(H7N9) Virus Infections of Humans Reported by WHO or in Chinese Provincial or Hong Kong CHP Press Releases, 18 Feb Feb 2018 (N=1,567)

3 Geographic Distribution 1 st through 4 th waves Influenza Heilongjiang Mongolia Inner Mongolia Jilin 2 Russia Nepal India Xinjiang 10 Tibet Bhutan India Bangladesh Qinghai Myanmar Thailand Sichuan Yunnan Gansu Ningxia Vietnam Laos Chongqing Guizhou 3 Shaanxi Guangxi 3 Shanxi Henan 4 Hubei 2 Hunan 34 Guangdong 195 Macao Hebei 4 Shandong 9 Anhui 38 Zhejiang Jiangxi Fujian 73 Hong Kong 16 Liaoning 1 Beijing 9 Tianjin 2 Taiwan 4 Jiangsu 103 North Korea Shanghai 50 South Korea Japan Geographic Distribution of 1 st 4 th Epidemics Confirmed Avian Influenza A(H7N9) Virus Human Infections*, March 2013-September 2016, (N=795) * Infections reported to WHO

4 Geographic Distribution 5 th wave Influenza Geographic Distribution of Fifth Epidemic Confirmed Avian Influenza A(H7N9) Virus Infections of Humans, Reported by WHO or in Chinese Provincial or Hong Kong CHP Press Releases, October 1, 2016-September 30, 2017 (N=766) Heilongjiang Mongolia Inner Mongolia 1 Jilin 1 Russia Nepal India Xinjiang 3 Tibet 3 Bhutan India Bangladesh Qinghai Myanmar Sichuan 38 Yunnan 7 Ningxia Gansu 5 Shaanxi 7 Chongqing 9 Guizhou 18 Vietnam Guangxi 28 Shanxi 3 Henan 24 Hubei 29 Hunan 61 Macao 2 Shandong 19 Anhui 63 Jiangxi 38 Fujian 34 Guangdong 63 Hong Kong 5 Liaoning 4 Beijing 27 Zhejiang 91 Taiwan 1 Thailand Laos Human Infections of A(H7N9) with HPAI mutation reported to WHO Human Infections of A(H7N9) with HPAI mutation identified by China CDC or Taiwan CDC LPAI human infections are by Province of Reporting; HPAI human infections are by Province of Exposure Hebei 25 Tianjin 3 Jiangsu 148 North Korea Shanghai 6 South Korea Japan

5 Older Men and Bird Markets Common in All 5 waves Influenza Age - Median 57 yrs (4 93 yrs) In contrast, H5N1 is 19 yrs (5 32) Gender - Male 70% Chronic Illness - At least one underlying disease in 53% Exposure - Poultry/live bird market exposure in 90% MMWR CDC and China CDC. Sept 2017; H5 Epi Lai et al Lancet 2016; China Daily/AFP

6 Severity in Human A(H7N9) Cases Persists in Wave 5 Influenza Severe disease - death 39% - pneumonia 90% - ICU admission 70% No sustained humanto-human transmission MMWR CDC and China CDC, Sept 2017; Photo: CGTN.

7 eb-2013 ar-2013 pr-2013 ay-2013 Jul-2013 ug-2013 ct-2013 ov-2013 ec-2013 an-2014 eb-2014 ar-2014 pr-2014 ay-2014 un-2014 ov-2014 ec-2014 an-2015 eb-2015 pr-2015 ec-2015 an-2016 eb-2016 ar-2016 pr-2016 ay-2016 un-2016 Jul-2016 ct-2016 ov-2016 ec-2016 an-2017 Evolution of Influenza A(H7) HA, H7N9 in the first 5 waves 5th epidemic H7N9 viruses Amino acid differences shown are relative to A/Shanghai/2/ A/Taiwan/3/2013 H7N9 A/Shanghai/5190T/2013 H7N9 A/Taiwan/1/2013 H7N9 A/pigeon/Zhejiang/P2/2013 H7N9 A/Taiwan/T02081/2013 H7N9 A/Zhenjiang/1/2013 H7N9 R47M A/Zhejiang/HZ1/2013 H7N9 A/Zhejiang/DTID-ZJU02/2013 H7N9 N190S A/chicken/Jiangsu/S002/2013 H7N9 A/Xuzhou/1/2013 H7N9 A/Suzhou/5/2013 H7N9 A/Nanjing/6/2013 H7N9 A/Huzhou/10/2013 H7N9 A/Nanjing/7/2013 H7N9 A/Wuxi/3/2013 H7N9 A/Huzhou/1/2013 H7N9 V24G A/Zhejiang/DTID-ZJU05/2013 H7N9 A/Zhejiang/DTID-ZJU08/2013 H7N9 A/Shanghai/07/2013 H7N9 A/Changsha/1/2013 H7N9 A/Beijing/1/2013 H7N9 A/chicken/Guangdong/SD641/20 13 H7N9 A/Shanghai/2/2013 H7N9 A/Wuxi/1/2013 H7N9 A/Anhui/1/2013 H7N9 Q213P A/Zhejiang/DTID-ZJU10/2013 H7N9 A/Zhejiang/22/2013 H7N9 A/Jiangsu/98342/2014 H7N9 A/chicken/Jilin/SD020/2014 H7N2 L168I S290N zzz A/silkie chicken/jiangxi/9469/2014 R47K R303K A/Zhejiang/LS01/2014 H7N9 A125V A125T V49I I280T A/Zhejiang/1/2016 H7N9 * T36K D109E z A/duck/Wenzhou/RAQL10/2 015 H7N9 * A/chicken/Zhangzhou/8585/ 2014 E104G V177A S237N D246V A/chicken/Shanghai/PD-CN -02/2 014 A/Huai'an/083/2014 H7N9 K2R R130K Q154H A/silkie chicken/huzhou/4213/2 013 N267D A/Hong Kong/214/2017 H7N9 E104K M227I A/Hong Kong/61/2016 H7N9 * N190S E104K N282K A/Guangdong/60923/2016 H7N9 * A/Hong Kong/VB /2016 H7N9 * E104R T156N T179I E104K A/chicken/Shantou/1550/2014 L168I A/Hong Kong/ /2014 H7N9 A/chicken/Guangdong/G1381/ 2014 H7N9 R47K N267D A/Hong Kong/5581/2014 H7N9 A74T S275N A9S A/chicken/Dongguan/1100/2014 mixed A/Hong Kong/4495/2014 H7N9 V177A A/Hong Kong/ /2014 H7N9 R47K I78V V262A N282K E104K A/Duck/Guangdong/DG103/2015 H7N9 * N267D A/Environment/Guangdong/DG127/ 2015 H7N9 * M256I N37S A/Guangdong/02496/2014 H7N9 G276R A/Hong Kong/2550/2015 H7N9 * A210E A/Hong Kong/ /2015 H7N9 * A/Chicken/Guangdong/DG592/2 014 H7N9 E25V T194I S207I R47K A/Duck/Guangdong/DG527/2014 H7N9 A/Guangdong/15SF010/2015 H7N9 * I280M I108L S134P Q213P G216A M227I S237N M256I N267D A/Hong Kong/5731/2014 H7N9 V264I N267G A/Hong Kong/3263/2014 H7N9 A/Hong Kong/ /2014 H7N9 A/silkie chicken/dongguan/1264/2014 D246E A/chicken/Shenzhen/138/2 014 V49I R47K A/silkie chicken/shantou/1406/2014 A/environment/Guangzhou/XN1291 7/2014 H7N9 A/environment/Guangzhou/XN0739 0/2014 H7N9 A/Hong Kong/ /2014 H7N9 A/Guangzhou/1/2014 H7N9 R47K T122A A/Shenzhen/SP-W1/2014 A/Guangdong/1/2013 H7N9 N282S N267D A/Hong Kong/470129/2013 H7N9 A/Hong Kong/5942/2013 H7N9 A/Hong Kong/734/2014 H7N9 T122A A/chicken/Shenzhen/712/2 013 mixed V86I R130K N282S R47K A/Guangdong/03/2013 H7N9 T116K R47K L217Q A/wild pigeon/jiangsu/sd001/2013 H7N9 A/chicken/Guangzhou/1/2 013 H7N9 A/chicken/Zhejiang/C481/2013 H7N9 A/chicken/Shanghai/S1410/2013 H7N9 A/pigeon/Wuxi/ G/2013 H7N9 L217Q A/Shanghai/JS01/2013 H7N9 G119E L217Q R130K R130K A/Environment/Guangdong/43966/ 2016 H7N9 * S118N A/Hong Kong/125/2017 H7N9 R130K A/Hong Kong/4553/2016 H7N9 * A/Hubei/39269/2016 H7N9 * R130K G261E A/Beijing/39450/2016 H7N9 * R130K A/Beijing/44066/2016 H7N9 * R130K A/Hebei/38604/2016 H7N9 * R130K N282S A/Environment/Hebei/40053/2016 H7N9 * A266D R130M N267Y R130K T122I M256I A/Jiangsu/15026/2016 A/Environment/Hebei/40052/2016 A/Environment/Hebei/40049/2016 H7N9 * H7N9 * H7N9 * R130M R130K T59A A/Hong Kong/793/2016 H7N9 * A/Anhui/45322/2016 H7N9 * A/Fujian/30766/2016 H7N9 * A/Hunan/02650/2016 H7N9 * A128V/A A/Fujian/4/2016 H7N9 * R130K A/Fujian/17527/2016 H7N9 * A/Fujian/54840/2016 H7N9 * K184N A/Fujian/45970/2016 H7N9 * A/Fujian/5/2016 H7N9 * K184N/K A/Jiangsu/15027/2016 H7N9 * A/Liaoning/44068/2016 K184N/K H7N9 * A/Jiangsu/05155/2016 H7N9 * A112T M227I S127G A/Tianjin/43917/2016 H7N9 A/Hunan/04137/2016 H7N9 * A/Hunan/04135/2016 H7N9 * A/Guangdong/16SF007/2016 H7N9 * I120T A/Fujian/3/2016 H7N9 * A/Hunan/06196/2016 H7N9 R130N * A/Anhui/26835/2016 H7N9 * R130K A/Guangdong/15SF871/2015 H7N9 * A/Environment/Guangdong/15125/ 2016 H7N9 * A/Fujian/30767/2016 H7N9 * S118N R130K V264I I317V A/Fujian/8/2016 H7N9 * A/Jiangsu/60454/2016 H7N9 * S118N R130K R303K A/Jiangsu/60460/2016 H7N9 * A/Jiangsu/60456/2016 H7N9 * S118N R130K M227L A292T A/Hunan/02286/2017 H7N9 A/Zhejiang/12/2016 H7N9 * A/Hebei/46587/2016 H7N9 * I38V A112T A/duck/Jiangsu/J3619/2014 H7N9 A/Jiangsu/03753/2016 H7N9 * T59I S118N R130K A/Jiangsu/06307/2014 H7N9 P212Q/P N17D A266V A/Environment/Jiangsu/03758/2015 H7N9 * A/Jiangsu/03756/2016 H7N9 * M256I I280V S218F M227I S118N A/Zhejiang/15/2016 H7N9 * A/Jiangsu/15028/2016 H7N9 * D367Y/D V86F I258V A/Anhui/26837/2016 H7N9 * A/Anhui/26836/2016 H7N9 * A/Anhui/40094/2015 H7N9 A125V A/Beijing/40610/2015 H7N9 * A/duck/Wenzhou/YJYF24/2015 H7N9 * A/Quzhou/1/2015 H7N9 * A/Guangdong/MZ828/2015 H7N9 * A/Environment/Guangdong/15120/ 2016 H7N9 * A/Environment/Guangdong/15123/ 2016 H7N9 * A112S S118N A/Guizhou/03240/2015 H7N9 * A/Fujian/09273/2015 H7N9 * G23E K319R A/Chicken/Guangdong/SW154/20 15 H7N9 * A/Shantou/2004/2015 H7N9 A/Fujian/10/2015 H7N9 * G133E D109E P206L A/Fujian/06198/2016 H7N9 * A/Fujian/1/2016 H7N9 * A/chicken/Wenzhou/HATS I101V R130K N282S LG01/2 015 H7N9 * A/Hunan/06197/2016 H7N9 * A/Environment/Hunan/10125/2015 H7N9 * V49I A/Environment/Hunan/10086/2016 H7N9 * A/Jiangsu/19758/2015 H7N9 * A/chicken/Anhui/A1065/2014 H7N9 A/Xinjiang/98692/2014 H7N9 R103K M256I D271I S118N E269V R130K S134P A/Xinjiang/05845/2015 H7N9 * A/duck/Anhui/A1618/2014 H7N9 L168I A/Huai'an/001/2015 H7N9 * S118N I288V A/chicken/China/028/2014 H7N9 I108L S218F I258V D289N A/Fujian/27/2015 H7N9 N37S S290R S118N A/British Columbia/1/2015 H7N9 * A/Fujian/18/2015 H7N9 * K184N G216D A/Fujian/5/2015 H7N9 A/goose/Jiangsu/J1111/2014 H7N9 A/Taiwan/2/2014 H7N9 A/Taiwan/1/2014 H7N9 R346K/R A/duck/Jiangxi/15044/2014 A/Huzhou/5/2013 H7N9 S304G A/Shanghai/PD-01/2014 P206S E269K A/Shanghai/Mix1/2014 H7N9 A/Shanghai/01/2014 H7N9 L217Q S127G R211G R47K L217P S281N L57R I38F L57R R252K S118N A/Jiangsu/60466/2016 H7N9 * A/Zhejiang/6/2016 H7N9 * A/Jiangsu/60451/2016 H7N9 * A/Fujian/02152/2017 H7N9 L217I A/Anhui/60936/2016 H7N9 * I120T A/Zhejiang/13/2016 H7N9 * A/Hunan/02285/2017 H7N9 A/Jiangsu/60459/2016 H7N9 * A/Jiangsu/60457/2016 H7N9 * V214F A/Jiangsu/60458/2016 H7N9 * A/Zhejiang/11/2016 H7N9 * A/Zhejiang/14/2016 H7N9 A/Jiangsu/60447/2016 H7N9 * A/Zhejiang/16/2016 H7N9 * S127N/S A/Zhejiang/10/2016 H7N9 * A/Jiangsu/60450/2016 H7N9 * P208T A/Zhejiang/9/2016 H7N9 * A/Hong Kong/VB /2016 H7N9 * A/Anhui/60931/2016 H7N9 * A/Anhui/60932/2016 H7N9 * A/Anhui/60933/2016 H7N9 * A/Anhui/60935/2016 H7N9 * A/Anhui/60934/2016 H7N9 * A/Anhui/60926/2016 H7N9 * V170I T126A/T V262A D271N R298K S281N/S G261R/G D271G Yangtze River Delta lineage Pearl River Delta lineage

8 A(H7N9) 5 th wave hemagglutinin changes compared to A/Shanghai/2/2013 (candidate vaccine virus) Pearl River Delta lineage Yangtze River Delta lineage S118N A125V M227I A112T R130K M227I E104K L168I L168I N267D E378A D340N N282K 180 rotation 180 rotation Not visible V425I S485R Site A - green Site B - brownish Site C - dark blue Site D - cyan Site E - yellow CHO orange HA2 changes in red

9 H7N9: Treatment Implications Influenza Division Antiviral Susceptibility Observing genetic markers of reduced susceptibility ~ 9-10% available NA gene segments Viruses typically recovered from patients treated with antivirals Antiviral Treatment China CDC had recommended early treatment with oseltamivir based on clinical presentation An H7N9 bird flu patient being treated in a hospital in Hubei province Photo: STAT News

10 Status of influenza A(H7N9) candidate vaccine viruses (CVV): March 2017 Vaccine Viruses CDC and other WHO CCs developed GLP candidate vaccine virus (CVV) using reverse genetics in 2013 A/Shanghai/2/2013 RG32A used for vaccine stockpile and clinical trials Candidate vaccine virus Type Institution Available A/Anhui/1/2013 (H7N9) IDCDC-RG33A Reverse Genetics CDC Yes A/Anhui/1/2013 (H7N9) NIBRG-268 Reverse Genetics NIBSC Yes A/Anhui/1/2013 (H7N9) NIIDRG-10.1 Reverse Genetics NIID Yes A/Anhui/1/2013 (H7N9) SJ005 Reverse Genetics SJCRH Yes A/Shanghai/2/2013 (H7N9) NIBRG-267 Reverse Genetics NIBSC Yes A/Shanghai/2/2013 (H7N9) CBER-RG4A Reverse Genetics FDA Yes A/Shanghai/2/2013 (H7N9) IDCDC-RG32A Reverse Genetics CDC Yes A/Shanghai/2/2013 (H7N9) IDCDC-RG32A.3 Reverse Genetics CDC Yes

11 Analysis of Human Viruses Available March 2017 Phylogenetics of HA vrna Genetic diversity Pearl RD antigenically similar Well-inhibited by antisera to existing CVVs Yangtze RD antigenically distinct Reduced cross-reactivity with sera to existing CVV fold reduced Emergence of HPAI viruses - genetically and antigenically distinct WHO VCM Meeting Confirmed significant antigenic changes in Yangtze RD viruses - China CDC - Hong Kong University CVVs Available A/Fujian/02152/ A/Jiangsu/06463/ A/Jiangsu/06454/2017 A/Anhui/60936/2016 A/Jiangsu/60466/2016 A/Jiangsu/15027/2016 A/Hunan/04137/2016 A/Jiangsu/15026/2016 A/chicken/Fujian/11089/2016 A/Hunan/02650/2016 A/silkie chicken/shantou/9473/2016 A/Anhui/60933/2016 A/Liaoning/44068/2016 A/Tianjin/43917/2016 A/Hubei/39269/2016 A/chicken/Fujian/11766/2016 A/Hong Kong/4553/2016 A/Hong Kong/125/2017 A/Fujian/30767/2016 A/Fujian/45970/2016 A/Fujian/54840/ A/Beijing/44066/2016 A/Hebei/38604/2016 A/Anhui/45322/2016 A/Jiangsu/60460/2016 A/Hunan/06196/2016 A/Jiangsu/18828/2014 A/Jiangsu/03753/ A/Hunan/06948/2017 A/Hebei/46586/2016 A/Jiangsu/15028/2016 A/chicken/Wenzhou/WZTSLG02/2015 A/Taiwan/1/2017 A/Guangdong/17SF003/ A/Guangdong/17SF006/2017 A/Environment/Guangdong/C / A/chicken/Jiangxi/14879/2015 A/Hunan/02287/2017 A/chicken/Guangzhou/4954/2016 A/Fujian/1/ A/Xinjiang/05916/ A/Fujian/18/ A/British_Columbia/1/2015 A/Taiwan/2/2014 A/Environment/Jiangsu/03137/2013 A/chicken/Jiangxi/18482/2014 A/Taiwan/1/2014 A/chicken/Wuxi/SC4315/2015 A/chicken/Guangzhou/1083/2016 A/Guangdong/60923/ A/Hong Kong/VB /2016 A/Guangdong/60061/ A/Hong Kong/VB / A/Hong Kong/214/ A/Guangdong/60060/ A/Guangdong/17SF004/2017 A/Hong Kong/ /2015 A/Shenzhen/SP195/2015 A/Guangdong/0012/2014 A/chicken/GD/874/2014 A/Guangdong-Guangzhou/XN08763/2014 A/Guangzhou/1/2014 A/Guangdong/SP38/2014 A/Hong Kong/5942/2013 A/Anhui/02/2013 A/chicken/Wenzhou/201/2014 A/Shandong/01/2014 A/Zhejiang/1/ A/Zhejiang/17/2014_W A/chicken/Shaoxing/5201/2013 A/Huaian/065/2014 A/ZJ/22/ A/Fujian/15/2014 A/Jiangsu/09387/2014 A/Shanghai/14/2013 A/Anhui/1/2013 A/Beijing/01-A/2013 A/Shanghai/2/2013 A/ZJ/DTID-ZJU05/2013 A/shanghai/05/2013 A/Shanghai/1/2013 HPAI Pearl River Delta Yangtze River Delta CDC and WHO, Feb 2017 VCM. Human viruses are in bold font. The available CVVs are in red. The proposed CVVs are indicated by a red dot.

12 IRAT Impact & Emergence Average Risk Scores Influenza Division Impact Risk H5N6 [A/Yunnan/../2015] H7N9 [A/Hong Kong/125/2017] H7N9 [A/Shanghai/../2013] H5N1 clade 1 [A/VN/../2004] 5 H5N8 [gyrfalcon/../2014] 4 H5N1 [Am. g-w teal/../2014] H5N2 [N. pintail/../2014] 3 2 H1N1 [A/duck/NY/96] 1 = no human cases = human cases Feb 2017 Emergence Risk

13 New A(H7N9) CVVs Recommended, WHO VCM March 2017 Influenza Division From WHO s Antigenic and genetic characteristics of zoonotic influenza viruses and candidate vaccine viruses developed for potential use in humans vaccines report, dated March 2, 2017.

14 CVV Development and Safety Testing Influenza Division Genetic Engineering Illustration by Jennifer Oosthuizen

15 H7N9 CVV Generation Influenza Division A/HK/125/2017 (H7N9) LPAI - Selected at February, 2017 WHO VCM Rescue and analysis - Good Laboratory Practice rescue and amplification - Sequence analysis of the HA gene low pathogenic influenza cleavage site - Genetic stability of the HA gene upon multiple passaging (10 passages) - Chicken embryo lethality - Pathogenicity analysis in ferrets

16 IDCDC-RG56B CVV Passed 2-way Antigenic Test IDCDC-RG56B HI reactivity patterns consistent with wild-type virus A/Hong Kong/125/2017 Antisera REFERENCE ANTIGENS Clade ML/NL HK/ 125 RG56B IDCDC-RG1 (Mallard/Netherlands/12/2000-like) A/Hong Kong/125/2017 YRD IDCDC-RG56B YRD TEST ANTIGENS A/Hong Kong/4553/2016 (LP) YRD A/Hong Kong/61/2016 (LP) PRD A/Hong Kong/214/2017 (LP) PRD A/Guangdong/17SF003/2016 (HP) YRD A/Taiwan/1/2017 (HP) YRD

17 A(H7N9) CVVs May, 2017

18 Engineering Additional Constructs and CVVs Influenza Division A/Hong Kong/125/2017 A/HK/125/2017 CVVs Receptor Binding Pocket C AS-B AS-D AS-A L217Q K130R T112P 180-helix 140-loop AS-C V/G177 H174 Y186 W142 K164E AS-E P/T212 Q/L217 Y loop 210-loop S/A128 CHO 1. L217Q->Yield and HPAI

19 Influenza Division Engineering Additional Constructs and CVVs A/Hong Kong/125/2017 A/HK/125/2017 CVVs A/Guangdong/16SF003/2016 AS-B AS-A K130R K130R AS-D L217Q T112P L217Q T112P R163K AS-C K164E G261R K164E AS-E I38T CHO Fusion peptide has polybasic insertion (RKRTA) Not visible E389K I317V V425I 1. L217Q->Yield and HPAI 2. HPAI-like 4 substitutions

20 mg HA/100 eggs Influenza Division HA Yield of A(H7N9) CVVs and Antigenic Testing 7 6 IDMS SDS-PAGE Low Pathogenic YRD HPAI YRD

21 mg HA/100 eggs Influenza Division HA Yield of A(H7N9) CVVs and Antigenic Testing IDMS Low Pathogenic YRD HPAI YRD SDS-PAGE Pass Fail Fail Fail Pass

22 A(H7N9) HPAI CVV November, 2017

23 Antigenic characterization of RG viruses (RG56B-derived) containing HA1 mutations identified in 5th wave viruses Influenza Division YRD lineage T112A I227M T112A V125A S134P I227M V49I I101V T112A N282S I227M T112A A292T S127G A/duck/Jiangsu/J3619/2014 H7N9 A/Jiangsu/03753/2016 H7N9 * A/Jiangsu/06307/2014 H7N9 A/Hong Kong/VB /2016 H7N9 * A/Jiangsu/15027/2016 H7N9 * D109E V262A A/Tianjin/43917/2016 H7N9 * A/Jiangsu/05155/2016 H7N9 * S165N A/Liaoning/44068/2016 H7N9 * A/Suzhou/78/2016 H7N9 * A/Suzhou/73/2016 H7N9 * A/Suzhou/92/2017 H7N9 * R303K I120T A/Jiangsu/60460/2016 H7N9 * A/Suzhou/60/2016 H7N9 * A/Suzhou/84/2016 H7N9 * A/Jiangsu/60454/2016 H7N9 * A/Suzhou/54/2016 H7N9 * A/Suzhou/56/2016 H7N9 * A/Jiangsu/60456/2016 H7N9 * A/Suzhou/80/2016 H7N9 A/Suzhou/67/2016 H7N9 * A/Environment/Guangdong/43966/2016 H7N9 * V264I A/Fujian/30767/2016 H7N9 * A/Fujian/8/2016 H7N9 * A/Fujian/4/2016 H7N9 * A/Fujian/02151/2017 H7N9 * A/Fujian/11/2017 H7N9 * A/Fujian/14/2017 H7N9 * A/Fujian/56600/2016 H7N9 * A/Fujian/54840/2016 H7N9 * A/Fujian/17527/2016 H7N9 * A/Fujian/45970/2016 H7N9 * A/Fujian/5/2016 H7N9 * H274Y A/Anhui/13425/2017 H7N9 * D85E A/Anhui/13424/2017 H7N9 * A/Anhui/13444/2017 H7N9 * A/Anhui/13428/2017 H7N9 * A/Anhui/13427/2017 H7N9 A/Anhui/13426/2017 H7N9 * A/Anhui/13434/2017 H7N9 * A/Anhui/60925/2016 H7N9 * A/Anhui/60926/2016 H7N9 A/Anhui/13436/2016 H7N9 * A/Anhui/60932/2016 H7N9 * A/Henan/11159/2017 H7N9 * R47L A/Henan/13705/2017 H7N9 * V262A A/Henan/13706/2017 H7N9 A/Henan/11157/2017 H7N9 * A/Anhui/60935/2016 H7N9 * A/Anhui/60934/2016 H7N9 * A/Anhui/60929/2016 H7N9 A/Anhui/13442/2017 H7N9 * A/Anhui/60933/2016 H7N9 * A/Anhui/60927/2016 H7N9 * A/Anhui/13431/2017 H7N9 * A/Anhui/13441/2017 H7N9 * A/Anhui/60928/2016 H7N9 A/Anhui/13421/2017 H7N9 * A/Anhui/60931/2016 H7N9 D271N A/Anhui/13439/2017 H7N9 * A/Anhui/13433/2017 H7N9 * A/Anhui/13432/2017 H7N9 A/Guangdong/16SF007/2016 H7N9 * A/Hunan/04137/2016 H7N9 * A/Fujian/30766/2016 H7N9 * A/Hunan/02650/2016 H7N9 * A/Hubei/39269/2016 H7N9 T122I M256I A/Jiangsu/15026/2016 H7N9 * A/Hong Kong/793/2016 H7N9 * A266D A/Environment/Hebei/40053/2016 H7N9 * G261E A/Hebei/38604/2016 H7N9 * A/Beijing/39450/2016 H7N9 * A/Fujian/3/2016 A/Anhui/45322/2016 H7N9 * H7N9 * A/Hong Kong/4553/2016 H7N9 * A/Hong Kong/125/2017 H7N9 * A/Guangdong/15SF871/2015 H7N9 * A/Environment/Guangdong/15125/2016 H7N9 * A/Guangxi/6/2017 H7N9 * A/Hebei/46587/2016 H7N9 * A/Hong Kong/VB /2017 H7N9 * A/Fujian/17/2017 H7N9 * I227L K184N A/Fujian/13558/2017 H7N9 * A/Zhejiang/5/2017 A/Zhejiang/18/2016 H7N9 H7N9 * VPT17-V12.4 * A/Xinjiang/98692/2014 H7N9 A/Xinjiang/05845/2015 H7N9 * A/Henan/11158/2017 H7N9 * A/Environment/Hunan/10125/2015 H7N9 * A/Hunan/02287/2017 H7N9 * A/Hunan/06197/2016 H7N9 * P208T A/Zhejiang/9/2016 H7N9 * A/Suzhou/88/2016 H7N9 * A/Jiangsu/60450/2016 H7N9 * A/Jiangsu/60461/2016 H7N9 * A151T Q202K A/Jiangsu/60465/2016 H7N9 * A/Suzhou/65/2016 H7N9 * A/Jiangsu/60462/2016 H7N9 * A/Zhejiang/4/2017 H7N9 * A/Hunan/00001/2016 H7N9 * V214F A/Jiangsu/60457/2016 H7N9 * A/Suzhou/57/2016 H7N9 * A/Changsha/41/2017 H7N9 * A/Chongqing/1/2017 H7N9 VPT17-V9.4 T156N A/Chongqing/2/2017 H7N9 * A/environment/ChongqingHC/2-20/2017 H7N9 * A/Guangxi/12219/2017 H7N9 * A/Guangxi/12218/2017 H7N9 * A/Suzhou/95/2017 H7N9 * A/Suzhou/96/2017 H7N9 * A/Jiangsu/60447/2016 H7N9 * A/Fujian/02152/2017 H7N9 * A/Zhejiang/14/2016 H7N9 * I120T A/Anhui/60936/2016 H7N9 * A/Zhejiang/8/2016 H7N9 * A/Zhejiang/11/2016 H7N9 * A/Zhejiang/13/2016 H7N9 * A/Jiangsu/60458/2016 H7N9 * A/Suzhou/58/2016 H7N9 * A/Suzhou/87/2016 H7N9 * A/Hubei/11951/2017 H7N9 * A/Hubei/11944/2017 H7N9 * A/Henan/11156/2017 H7N9 * A/Jiangsu/60459/2016 H7N9 * A/Suzhou/59/2016 A/Jiangsu/11581/2017 H7N9 * H7N9 * A/Zhejiang/17/2016 H7N9 * A/Anhui/60924/2016 H7N9 * A/Zhejiang/2/2017 H7N9 * A/Hunan/02285/2017 H7N9 * A/Jiangsu/11554/2017 H7N9 * A/Jiangsu/11553/2017 H7N9 * A/Zhejiang/1/2017 H7N9 * A/Hubei/11950/2017 H7N9 * A/Suzhou/74/2016 H7N9 * A/Jiangsu/11556/2017 H7N9 * A/Jiangsu/11557/2017 H7N9 * A/Jiangsu/11555/2017 H7N9 * A/Suzhou/91/2017 H7N9 * A/Jiangsu/11589/2017 H7N9 * A/Suzhou/86/2016 H7N9 * A/Zhejiang/16/2016 H7N9 * A/Jiangsu/11587/2017 H7N9 * A/Jiangsu/11586/2017 H7N9 A/Jiangsu/11590/2017 H7N9 * A/Jiangsu/11588/2017 H7N9 * A/Liaoning/13454/2017 H7N9 * A/Suzhou/90/2017 H7N9 * A/Suzhou/93/2017 H7N9 A/Jiangsu/11583/2017 H7N9 * A/Jiangsu/11585/2017 H7N9 A/Zhejiang/7/2016 A/Zhejiang/10/2016 H7N9 H7N9 * * A/Jiangsu/60452/2016 H7N9 * A/Suzhou/51/2016 H7N9 * A/Jiangsu/60451/2016 H7N9 * A/Zhejiang/6/2016 H7N9 * A/Jiangsu/60466/2016 H7N9 * A/Suzhou/79/2016 H7N9 * A/Jiangsu/60467/2016 H7N9 * A/Jiangsu/60463/2016 H7N9 A/Suzhou/63/2016 H7N9 * V93M A/Suzhou/467/2016 H7N9 * A/Zhejiang/3/2017 H7N9 A/Zhejiang/19/2016 H7N9 * A/Changsha/58/2017 H7N9 * A/Changsha/44/2017 H7N9 A/Fujian/12/2017 H7N9 * A/Fujian/8/2017 H7N9 * A/Yunnan/13501/2017 H7N9 * A/Hunan/02286/2017 H7N9 * A/Jiangxi/10683/2017 H7N9 * A/Zhejiang/12/2016 H7N9 * A/Yunnan/13500/2017 H7N9 * A/Zhejiang/6/2017 H7N9 * A/Zhejiang/20/2016 H7N9 * A/Anhui/13446/2017 H7N9 * A/Anhui/13447/2017 H7N9 * A/Anhui/13449/2017 H7N9 * A/Anhui/13423/2017 VPT17-V8.4 A/Henan/14905/2017 H7N9 * A/Henan/15337/2017 H7N9 * A/Changsha/26/2017 H7N9 * H A/Guangdong/17SF064/2017 H7N9 * HPAI and PRD lineage T112A V125A S134P I227M A/Guangzhou/1/2014 H7N9 A/Hong Kong/5942/2013 H7N9 V125A I168L I227M A/Hong Kong/734/2014 H7N9 A/Guangdong/03/2013 H7N9 R47K A/Shenzhen/SP-W1/2014 T112A N118S V125A T122A R47K K130R A/Guangdong/1/2013 H7N9 K130R I168L I227M A/Shanghai/5190T/2013 H7N9 A/Taiwan/1/2013 H7N9 A/pigeon/Zhejiang/P2/2013 H7N9 A/Taiwan/T02081/2013 H7N9 V125A I168L Q213P A/Zhejiang/DTID-ZJU10/2013 H7N9 A/Zhejiang/22/2013 H7N9 T112A N118S K130R I227M V49I I280T V125A I168L A/chicken/Zhangzhou/8585/2014 A/chicken/Shanghai/PD-CN-02/2014 R47K R303K A/Jiangsu/98342/2014 H7N9 A/silkie chicken/jiangxi/9469/2014 A/Zhejiang/LS01/2014 H7N9 T112A N118S V125A I168L A/chicken/Jilin/SD020/2014 H7N2 K130R I168L I227M A/Shanghai/Mix1/2014 H7N9 A/Shanghai/01/2014 H7N9 T112A N118S V125A A/Taiwan/3/2013 H7N9 A/Shanghai/07/2013 H7N9 K130R I168L I227M A/Changsha/1/2013 H7N9 A/Beijing/1/2013 H7N9 T112A N118S V125A A/Anhui/1/2013 H7N9 K130R I168L I227M R47M A/Zhenjiang/1/2013 H7N9 A/chicken/Jiangsu/S002/2013 H7N9 N190S A/Xuzhou/1/2013 H7N9 A/Suzhou/5/2013 H7N9 T112A N118S V125A A/Nanjing/6/2013 H7N9 K130R I168L I227M A/chicken/Guangdong/SD641/2013 H7N9 A/Shanghai/2/2013 H7N9 A/Wuxi/1/2013 H7N9 A/pigeon/Wuxi/ G/2013 H7N9 A/Shanghai/JS01/2013 H7N9 V177G A/Shanghai/1/2013 H7N9 V177G Yangtze River delta A/Xinjiang/98692/2014 H7N9 A/Xinjiang/05845/2015 H7N9 * V49I I101V T112A N282S A/Henan/11158/2017 H7N9 * A/Environment/Hunan/10125/2015 H7N9 * A/Hunan/02287/2017 H7N9 * I227M A/Hunan/06197/2016 H7N9 * H A/Guangdong/17SF064/2017 H7N9 * H A/Environment/Guangzhou/K4072/2016 H7 * H A/Environment/Guangdong/KGZ4048/2016 H7 * P112S F115L HPAI H A/Environment/Guangdong/KGZ4068/2016 VPT17-V15.4 H A/Environment/Guangdong/KGZ4075/2016 H7 * H A/Environment/Guangdong/C /2016 H7 * H A/Environment/Guangdong/C /2016 H7 * K163R R261G R320G H A/Environment/Guangdong/C /2016 H7 * H A/Environment/Guangdong/C /2016 H7N9 * R22K K163R I169V R261G H A/Guangdong/17SF037/2017 H7N9 * A/Guangdong/17SF059/2017 H7N9 H A/Guangdong/17SF033/2017 H7N9 * H A/Guangxi/7/2017 H7N9 * H A/Guangxi/1/2017 H7N9 * D148N A150T S203F H A/Guangxi/4/2017 H7N9 * Q217L H A/Taiwan/1/2017 H7N9 * H A/Guangdong/8H324/2017 H7N9 * H A/Guangdong/17SF003/2016 VPT17-V13.4 H A/Guangdong/17SF032/2017 H7N9 * K130R H A/Guangdong/17SF006/2017 H7N9 * VPT17-V14.4 H A/Guangdong/17SF039/2017 H7N9 * K163R R261G H A/Guangdong/17SF062/2017 H7N9 * V205I A/Environment/Guangdong/15120/2016 H7N9 * T112A A/Fujian/1/2016 H7N9 * A/Jiangsu/19758/2015 H7N9 * A/chicken/Wenzhou/HATSLG01/2015 H7N9 * A/Shantou/2004/2015 H7N9 I227M A/Guizhou/03240/2015 H7N9 * A/Guangdong/MZ828/2015 H7N9 * A/Chicken/Guangdong/SW154/2015 H7N9 * T112A A/Fujian/10/2015 H7N9 * N17D A266V A/Jiangsu/03756/2016 H7N9 * A/Zhejiang/15/2016 H7N9 * I227M V86F A/Jiangsu/11550/2017 VPT17-V11.4 A/Jiangsu/15028/2016 H7N9 * A/Anhui/26836/2016 H7N9 * T112A K130R I258V I227M A/Anhui/40094/2015 H7N9 A/Beijing/40610/2015 H7N9 * T112A V125A K130R I227M I288V A/duck/Wenzhou/YJYF24/2015 H7N9 * A/Quzhou/1/2015 H7N9 * A/Huai'an/001/2015 H7N9 * A/chicken/China/028/2014 H7N9 V125A N37S K130R S290R A/British Columbia/1/2015 H7N9 * A/Fujian/5/2015 H7N9 A/Taiwan/2/2014 H7N9 A/Taiwan/1/2014 H7N9 T112A N118S I227M A/duck/Jiangxi/15044/2014 K130R A/Guangxi/2/2017 H7N9 * E104K I227M V125A A/Changsha/70/2017 H7N9 * A/Hong Kong/214/2017 H7N9 * N267D A/Guangdong/60060/2016 H7N9 * A/Hong Kong/61/2016 H7N9 * A/Guangdong/60061/2016 H7N9 * V125A A/Guangdong/60923/2016 H7N9 * VPT17-V10.7 K130R N190S A/Hong Kong/VB /2016 H7N9 * A/Guangdong/15SF010/2015 H7N9 * A/Hong Kong/ /2014 H7N9 V177A N267D A/Duck/Guangdong/DG103/2015 H7N9 * M256I A/Environment/Guangdong/DG127/2015 H7N9 * E104K V125A A/Hong Kong/ /2015 H7N9 * G276R A/Hong Kong/2550/2015 H7N9 * A/Guangdong/02496/2014 H7N9 I227M A/chicken/Shantou/1550/2014 A/Hong Kong/ /2014 H7N9 A/Hong Kong/5731/2014 H7N9 T112A A/chicken/Guangdong/G1381/2014 H7N9 N118S R47K A/Hong Kong/5581/2014 H7N9 N267D A/Hong Kong/4495/2014 H7N9 A/Hong Kong/3263/2014 H7N9 A/Hong Kong/ /2014 H7N9 R47K K130R A/Hong Kong/ /2014 H7N9 A/Zhejiang/1/2016 H7N9 * A/duck/Wenzhou/RAQL10/2015 H7N9 * H A/Guangxi/5/2017 H7N9 * A/Guangxi/3/2017 H7N9 H A/chicken/Heinan/ZZ01/2017 H7N9 * Pearl River delta 0.005

24 Antigenic Diversity of A(H7N9) viruses produced by reverse genetics and derived from the RG56B (YRD) virus Boosted Boosted REFERENCE ANTIGENS Mutations ML/NL/12 RG 1 RG 56B RG56N 1 A/mld/Neth/12/ IDCDC-RG56B A/Hong Kong/125/2017 x PR IDCDC-RG56N^ T112P, K130R, K164E, L217Q VPT17-V13.4 * I38T, T112P, K130R, R163K, K164E, L217Q, G261R TEST ANTIGENS 5 VPT17-V10.7* E104R, T112A, N118S, V125A, K130R, T156N, T179I, N190S, N267D VPT17-V8.4* D109E, S127G, N146S, V262A VPT17-V9.4* T156N, V214I, G216D VPT17-V11.4* N17D, T59I, V86F, T112A, K130R, I227M, I258V, A266V VPT17-V12.4* T112A, K184N, I227L, A292T VPT17-V14.4* I38T, T112P, K130R, K164E, L217Q VPT17-V15.4* I38T, T112S, F115L, K130R, K164E, L217Q GD/ 17SF003 ^RG56N is a reverse genetics generated virus derived from RG56B with HA1 mutations that are conserved in HPAI A(H7N9) viruses *VPT17 antigens are reverse genetics generated viruses derived from RG56B with HA1 mutations identified in wt 5th wave viruses.

25 Clinical Trials Using IDCDC-RG56B Started: February, 2018 Influenza

26 Status of A(H7N9) CVVs March, 2018 Influenza Candidate vaccine virus Reactivity Institute Status IDCDC-RG56B Cross-reactive with YRD and PRD; (A/Hong Kong/125/2017-like) Does not cross-react with HPAI viruses CDC Available CNIC-HN02650 Cross-reactive with YRD and PRD; (A/Hunan/02650/2016-like) Does not cross-react with HPAI viruses China CDC Available IDCDC-RG56N Cross-reactive with LPAI and HPAI 5 th and (A/Guangdong/17SF003/2016-like) 6 th wave viruses tested CDC Available CNIC-GD003 Cross-reactive with LPAI and HPAI 5 th and (A/Guangdong/17SF003/2016-like) 6 th wave viruses tested China CDC Pending NIBRG-375 Cross-reactive with LPAI and HPAI 5 th (A/Guangdong/17SF003/2016-like) wave viruses tested NIBSC Pending CBER-RG7C Cross-reactive with LPAI and HPAI 5 th (A/Guangdong/17SF003/2016-like) wave viruses tested FDA/CBER Pending

27 A(H7N9) Summary of A(H7N9) 5th Wave 2016/2017 wave 5 epidemic -> dramatic increase in zoonosis ~ half of total cases (i.e., 766 of 1,567) Geographic dissemination Severe disease (38-40% CFR) Genetic drift of the HA viral RNA segment Pearl river delta viruses Well-inhibited by antisera to existing CVVs Yangtze River Delta HA group Predominant viruses in W5 Emergence of HPAI viruses Antigenically distinct Reduced cross-reactivity with sera to existing CVVs WHO VCM MAR, > New CVVs for low pathogenic and high pathogenic New CVVs engineered by reverse genetics (antigenicity and yield) IDCDC-RG56B (LP), antisera inhibits diverse LP viruses Clinical trial starting IDCDC-RG56N (HP), antisera broadly cross-reactive Others against HP becoming available

28 Acknowledgments Virology, Surveillance and Diagnosis Branch David Wentworth Vivien Dugan Larisa Gubareva Becky Garten Steve Lindstrom Xu Xiyan John Barnes Sam Shephard Zoonotic Virus Team, Todd Davis Yunho Jang Atanaska Marinova-Petkova Sharmi Thor Han Di Natosha Zanders Patrick Yang Joyce Jones Erin Hodges Vaccine Preparedness Team, Vivien Dugan (acting TL) Guaniri Mateu-Petit Pavani Bondugula Jaber Hossain Adam Johnson Xudong Lin Callie Ridenour Li Wang Terianne Wong International Research and Epidemiology Team, EPB Eduardo Azziz-Baumgartner James Kile Danielle Iuliano Katherine Roguski National Veterinary Services Laboratory, USDA Mia Torchetti Nicole Hines Influenza Division, OD Dan Jernigan Jackie Katz James Stevens Sue Trock Alicia Fry Director, Influenza Program U.S. CDC-China Office Carolyn Greene China CDC Shu Yuelong Dayan Wang Taiwan CDC Ji-Rong Yang Centre for Health Protection, Hong Kong Janice Lo University of Hong Kong Yi Guan Tommy Lam Zhu Hua Chen

29 Extra

30 Mar 16, 2018 Geographic Distribution Geographic Distribution of Sixth Epidemic Confirmed Avian Influenza A(H7N9) Virus Infections of Humans, Reported by WHO or in Chinese Provincial or Hong Kong CHP Press Releases, October 1, Feb 2018 (N=3)* Mongolia Inner Mongolia Jilin Heilongjian g Russi a Nepa l India Xinjiang 1 Tibet Bhuta n Banglades h India Qinghai Sichuan Yunnan 1 Gansu Chongqing Guizhou Shaanxi Guangxi Henan Shandon g Liaonin g Myanmar Vietnam Macao Hong Kong Thailan Laos Human Infections of A(H7N9) with HPAI d mutation identified by China CDC or Taiwan CDC * LPAI human infections are by Province of Reporting; HPAI human infections are by Province of Exposure Ningxi a Shanxi Hubei Hunan Hebei Jiangxi Guangdong 1 Anhui Fujian Beijin g Tianjin Zhejian g Taiwan Jiangsu North Korea Shangha i South Korea Japa n

31 HPAI H5 outbreaks animals - Reported to OIE and/or FAO; data is from OIE and FAO open sources that are available online H5N6 Ireland It Laboratory Zoonotic Influenza March 6-12, 2018 H5NX Bulgaria (1) H5N8 Italy(1) Iraq (2) Ir I H5N6 China(1) H5N6 Japan (3) H5N2 Taiwan (1) H5NX H5N1 H5N2 H5N3 H5N5 H5N6 H5N8 H5N1 India (1) Captive Birds Domestic Poultry Wild bird

32 Laboratory Zoonotic Influenza Reported February 27- March 5, 2018 A(H5) and A(H9N2) - No influenza A(H5) or A(H9N2) viruses were isolated or characterized antigenically Newly detected HPAI H5 outbreaks in animals Country Number of Outbreaks/reports Observation Date *Reported to OIE and/or FAO; data is from OIE and FAO open sources that are available online Species Description Bulgaria (H5) 1 2 March 2018 Domestic poultry India (H5N1) 1 11 Feb 2018 Domestic poultry China (H5N6) 1 22 Feb 2018 Domestic poultry Japan (H5N6) 3 1,2,3 March 2018 Wild bird Ireland (H5N6) 1 23 Feb 2018 Wild bird Iraq (H5N8) 2 4,5 March 2018 Domestic poultry Italy (H5N8) 1 2 March 2018 Domestic poultry Taiwan (H5N2) 1 24 Feb 2018 Domestic poultry

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness February 2014 The development of representative candidate influenza

More information

HPAI. Update of H7N9 in china:the epidemiological and virological features LPAI. H7N9 avian influenza viruses (before 2013)

HPAI. Update of H7N9 in china:the epidemiological and virological features LPAI. H7N9 avian influenza viruses (before 2013) Update of H7N9 in china:the epidemiological and virological features Yuelong Shu WHO Collaborating Center for Reference and Research on Influenza Chinese National Influenza Center National Institute for

More information

Corporate Leadership Forum March Briefing March 11, 2015

Corporate Leadership Forum March Briefing March 11, 2015 Center for Infectious Disease Research and Policy University of Minnesota Corporate Leadership Forum March Briefing March 11, 2015 Michael T. Osterholm, PhD, MPH McKnight Presidential Endowed Chair in

More information

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness 4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2018 The development of influenza candidate vaccine

More information

China HPAI Situation - Update

China HPAI Situation - Update JUNE 2012 NO.6 China HPAI Situation - Update CHINA ECTAD-CHINA HPAI Outbreak Situation Update (2010 - e 2012) HPAI Surveillance Situation Update (2010-2011) HPAI H5N1 Virus Monitoring and New Vaccine Development

More information

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges? Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)

More information

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2014 The development of representative candidate influenza

More information

HO Global Influenza Program: Human-Animal Interface Team) PAI Activities FAO/OIE/WHO Tripartite Animal Health Meeting.

HO Global Influenza Program: Human-Animal Interface Team) PAI Activities FAO/OIE/WHO Tripartite Animal Health Meeting. 2007 FAO/OIE/WHO Tripartite Animal Health Meeting HO Global Influenza Program: Human-Animal Interface Team) PAI Activities 1 January 2007 iz Mumford ike Perdue ui-hong Chung Current Activities WHO Working

More information

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2013 The development of representative candidate influenza

More information

Influenza at the human-animal interface

Influenza at the human-animal interface Influenza at the human-animal interface Summary and assessment, 17 January to 14 February 2017 New infections 1 : Since the previous update, new human infections with influenza A(H7N9) and A(H1N1)v viruses

More information

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness 4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2015 The development of candidate influenza vaccine

More information

Possible pandemic threat from new reassortment of influenza A(H7N9) virus in China

Possible pandemic threat from new reassortment of influenza A(H7N9) virus in China Rapid communications Possible pandemic threat from new reassortment of influenza A(H7N9) virus in China Z Meng 1, R Han 2, Y Hu 1, Z Yuan 1, S Jiang 1, X Zhang 1,3, J Xu (jianqingxu2008@gmail.com) 1,3

More information

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness 4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2017 The development of candidate influenza vaccine

More information

Polio Bulletin 2014 Issue No Week 25 (as of 23 Jun 2014)

Polio Bulletin 2014 Issue No Week 25 (as of 23 Jun 2014) Non-polio AFP rate Cases with adequate specimens (%) HIGHLIGHTS T e c h n i c a l A d v i s o r y G r o u p m e e t i n g, Manila, 17-20 June 2014 The 23rd meeting of the Technical Advisory Group (TAG)

More information

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness 4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness February 2018 The development of influenza candidate vaccine

More information

Global and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness

Global and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness Global and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness Takato Odagiri Director WHO Collaborating Center on Influenza, Tokyo and Influenza Virus Research Center, National

More information

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 26, influenza activity level in mainland China was very low, only a few A(H1N1)pdm09

More information

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report National Institute for Viral Disease Control and Prevention, China CDC Chinese Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 17, influenza activity

More information

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 23, influenza activity level in mainland China was very low, only a few influenza

More information

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 27, influenza activity level in mainland China was very low, only a few influenza

More information

Avian Influenza A(H7N9) 13 February 2014 Surveillance Update

Avian Influenza A(H7N9) 13 February 2014 Surveillance Update Avian Influenza A(H7N9) 13 February 2014 Surveillance Update Summary The WHO has reported 337 human infections including 66 deaths with onset since February 2013. There are still no signs of ongoing, efficient,

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 18/09/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening

More information

Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season

Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere 2015-16 Influenza Season Jacqueline Katz, Ph. D. Deputy Director (acting), Influenza Division

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 10/07/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 28/02/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and

More information

OFFLU AVIAN INFLUENZA REPORT

OFFLU AVIAN INFLUENZA REPORT OFFLU AVIAN INFLUENZA REPORT Avian Influenza Events in Animals for the period February to September 2017 Scope In this document we present a summary of H5, H7, and H9 avian influenza events that occurred

More information

Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E,

Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, TY93/H5N1 GFP-627K, or the TY93/H5N1 PB2(588-759) virus library. To establish our GFP- FACS screening platform, we compared

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 24/04/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 31/05/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

More information

Influenza A(H5N1) activity from 27 September 2010 to 15 February 2011

Influenza A(H5N1) activity from 27 September 2010 to 15 February 2011 Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for the development of candidate vaccine viruses for pandemic preparedness February 2011 The development of representative

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 25/01/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and strains within

More information

Malaria Situation and Control in China

Malaria Situation and Control in China Malaria Situation and Control in China Dr Guan Yayi National Institute of Parasitic Diseases, China CDC March 16, 2010 Luang Prabang, Lao PDR Malaria in China (1952-2009) 0 50 100 150 200 250 300 1952

More information

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of

More information

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Oscar Blanch-Lombarte Rome, 7-9 June, 2017 European

More information

H5N1 avian influenza: timeline

H5N1 avian influenza: timeline H5N1 avian influenza: timeline 28 October 2005 Previous events in Asia 1996 Highly pathogenic H5N1 virus is isolated from a farmed goose in Guangdong Province, China. 1997 Outbreaks of highly pathogenic

More information

The A(H7N9) influenza outbreak in China

The A(H7N9) influenza outbreak in China Viruses in May, Katoomba, 9 11 May 2013 The A(H7N9) influenza outbreak in China Anne Kelso Director WHO Collaborating Centre for Reference and Research on Influenza Melbourne Influenza in the 21 st century:

More information

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with Supplementary Figure 1 Weight and body temperature of ferrets inoculated with A/Anhui/1/2013 (H7N9) influenza virus. (a) Body temperature and (b) weight change of ferrets after intranasal inoculation with

More information

Avian Influenza A(H7N9) 6 February 2014 Surveillance Update

Avian Influenza A(H7N9) 6 February 2014 Surveillance Update Avian Influenza A(H7N9) 6 February 2014 Surveillance Update Summary The WHO has reported 298 human infections including 63 deaths with onset since February 2013. There are still no signs of ongoing, efficient,

More information

Contribution of avian influenza data through OFFLU network

Contribution of avian influenza data through OFFLU network Dr Gounalan Pavade Chargé de Mission, OIE Headquarters Contribution of avian influenza data through OFFLU network Asia-Pacific Workshop on surveillance, prevention and control of zoonotic influenza Paro,

More information

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus H7N9 Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus RNA virus, Orthomyxoviruses Influenza A virus Eight Gene segments

More information

OFFLU contribution to the WHO vaccine selection meeting

OFFLU contribution to the WHO vaccine selection meeting OFFLU contribution to the WHO vaccine selection meeting WHO Consultation on the Composition of Influenza Vaccines for the Southern Hemisphere 0 (0- Feb 0, Geneva) Giovanni Cattoli OFFLU Annual technical

More information

Public health relevant virological features of Influenza A(H7N9) causing human infection in China

Public health relevant virological features of Influenza A(H7N9) causing human infection in China Public health relevant virological features of Influenza A(H7N9) causing human infection in China Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 08/05/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening

More information

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update 30 August 2013 Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update Alert and Response Operations International Health Regulations, Alert and Response and Epidemic

More information

Update on Zoonotic Infections with Variant Influenza A Viruses in the USA

Update on Zoonotic Infections with Variant Influenza A Viruses in the USA Update on Zoonotic Infections with Variant Influenza A Viruses in the USA Todd Davis Zoonotic Virus Team Virology, Surveillance and Diagnosis Branch Influenza Division CDC, Atlanta OFFLU Swine Influenza

More information

OFFLU AVIAN INFLUENZA POST VCM REPORT

OFFLU AVIAN INFLUENZA POST VCM REPORT OFFLU AVIAN INFLUENZA POST VCM REPORT Avian Influenza Events for the period September 2017 to February 2018 Scope In this document we present a summary of H5, H7, and H9 avian influenza events that occurred

More information

Regional Overview of the implementation of National Control Strategies for Avian Influenza. Summary review of questionnaire OIE RRAP

Regional Overview of the implementation of National Control Strategies for Avian Influenza. Summary review of questionnaire OIE RRAP Regional Overview of the implementation of National Control Strategies for Avian Influenza Summary review of questionnaire OIE RRAP The OIE Questionnaire on Influenza A surveillance in animals in the Asia

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Linderman GC, Lu J, Lu Y, et al. Association of body mass index with blood pressure among 1.7 million Chinese adults. JAMA Netw Open. 2018;1(4):e181271. doi:10.1/jamanetworkopen.2018.1271

More information

Japanese Encephalitis in Mainland China

Japanese Encephalitis in Mainland China Jpn. J. Infect. Dis., 62, 331-336, 2009 Review Japanese Encephalitis in Mainland China Wang Huanyu, Li Yixing 1, Liang Xiaofeng 1, and Liang Guodong* State Key Laboratory for Infectious Disease Control

More information

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA David L. Suarez Southeast Poultry Research Laboratory, Exotic and Emerging Avian Viral Diseases Research

More information

Quantifying predictors for the spatial diffusion of avian influenza virus in China

Quantifying predictors for the spatial diffusion of avian influenza virus in China Lu et al. BMC Evolutionary Biology (2017) 17:16 DOI 10.1186/s12862-016-0845-3 RESEARCH ARTICLE Quantifying predictors for the spatial diffusion of avian influenza virus in China Lu Lu 1, Andrew J. Leigh

More information

IMMUNITY TO INFLUENZA INFECTION. Unit 7 Paul Thomas Department of Immunology St. Jude Children s Research Hospital

IMMUNITY TO INFLUENZA INFECTION. Unit 7 Paul Thomas Department of Immunology St. Jude Children s Research Hospital IMMUNITY TO INFLUENZA INFECTION Unit 7 Paul Thomas Paul.Thomas@stjude.org Department of Immunology St. Jude Children s Research Hospital INFLUENZA A VIRUS Negative sense, segmented RNA virus Orthomyxoviridae

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 30/06/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

More information

Avian Influenza/Newcastle Disease Virus Subcommittee

Avian Influenza/Newcastle Disease Virus Subcommittee Avian Influenza/Newcastle Disease Virus Subcommittee David L. Suarez D.V.M., Ph.D. Patti Miller D.V.M., Ph.D. Claudio Afonso Ph.D. Southeast Poultry Research Laboratory United States National Poultry Research

More information

Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013

Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013 Rapid communications Human infection with avian influenza A(H7N9) virus re-emerges in in winter 2013 E Chen 1,2, Y Chen 1,2, L Fu 2,3, Z Chen 1, Z Gong 1, H Mao 1, D Wang 4, M Y Ni 5, P Wu 5, Z Yu 1, T

More information

Origins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings

Origins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings Origins and evolutionary genomics of the novel 2013 avian-origin H7N9 influenza A virus in : Early findings Jiankui He*, Luwen Ning, Yin Tong Department of Biology, South University of Science and Technology

More information

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks INFLUENZA VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks PATHOGENICITY High pathogenicity avian influenza (HPAI) Causes severe disease in poultry

More information

Avian influenza viruses from the global perspective

Avian influenza viruses from the global perspective Avian influenza viruses from the global perspective Wenqing Zhang SARI Surveillance in the Americas (SARInet) Meeting 28-30 April 2015 Cancun, Mexico Complex modern world Increasingly crowded Growth in

More information

To test the possible source of the HBV infection outside the study family, we searched the Genbank

To test the possible source of the HBV infection outside the study family, we searched the Genbank Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),

More information

Todd Davis Influenza Division Centers for Disease Control and Prevention Atlanta, GA USA

Todd Davis Influenza Division Centers for Disease Control and Prevention Atlanta, GA USA OFFLU influenza virus meeting 27 28 March 2017 FAO Headquarters, Rome, Italy Todd Davis Influenza Division Centers for Disease Control and Prevention Atlanta, GA USA Strains of concerns Influenza A(H3N2)v

More information

Qualitative risk assessment update

Qualitative risk assessment update February 2019 ANIMAL HEALTH RISK ANALYSIS ASSESSMENT No. 8 Chinese-origin H7N9 avian influenza spread in poultry and human exposure Qualitative risk assessment update FAO/Xavier Roche The current risk

More information

For the control of avian influenza

For the control of avian influenza OIE Regional Expert Group Meeting for the Control of Avian influenza in Asia Sapporo, 3-5 October 2017 For the control of avian influenza Hiroshi Kida Hokkaido University Research Center for Zoonosis Control

More information

GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA

GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA Dr Gounalan Pavade OIE Regional Expert Group Meeting for the Control of Avian Influenza in Asia Sapporo, Japan 3-5 October 2017 1 Avian influenza Outbreaks

More information

Avian Influenza (AI) National & International Update

Avian Influenza (AI) National & International Update Avian Influenza (AI) National & International Update T.J. Myers, F. Hegngi, A. Rhorer, P. Klein, T. Duvernoy & M. David USDA, APHIS, Veterinary Services Delmarva Breeder, Hatchery & Grow Out Conference

More information

Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use in human vaccines

Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use in human vaccines Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use in human vaccines September 2008 It is not known if the next influenza pandemic will

More information

Western Pacific Regional Office of the World Health Organization

Western Pacific Regional Office of the World Health Organization Western Pacific Regional Office of the World Health Organization Avian Influenza Weekly Update Number 420 (14 February 2014) http://www.wpro.who.int/emerging_diseases/avianinfluenza/en/index.html Human

More information

Research Issues in Animal Surveillance and Pandemic Planning

Research Issues in Animal Surveillance and Pandemic Planning Research Issues in Animal Surveillance and Pandemic Planning Robert G. Webster, PhD Division of Virology Department of Infectious Diseases St. Jude Children s Research Hospital SURVEILLANCE Spread of H5N1

More information

Improving Care for Cardiovascular Disease in China: A collaborative project of AHA and CSC (The CCC Project) Project Progress

Improving Care for Cardiovascular Disease in China: A collaborative project of AHA and CSC (The CCC Project) Project Progress Improving Care for Cardiovascular Disease in China: A collaborative project of AHA and CSC (The CCC Project) Project Progress Beijing Anzhen Hospital, Capital Medical University Beijing Institute of Heart

More information

INFLUENZA-2 Avian Influenza

INFLUENZA-2 Avian Influenza INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature

More information

Avian Influenza Viruses with Pandemic Potential

Avian Influenza Viruses with Pandemic Potential Avian Influenza Viruses with Pandemic Potential Takato Odagiri Director WHO Collaborating Center on Influenza, Tokyo and Influenza Virus Research Center, National Institute of Infectious Diseases, Japan

More information

Influenza A (H7N9) Control in China

Influenza A (H7N9) Control in China Influenza A (H7N9) Control in China Zhang Zhongqiu China Delegate to OIE DG, Veterinary Bureau, Ministry of Agriculture, the People s Republic of China 2013.05.30 Outline 1. Human cases of H7N9 2. Control

More information

Review of Avian Influenza A(H5N1) for WHO SAGE

Review of Avian Influenza A(H5N1) for WHO SAGE Review of Avian Influenza A(H5N1) for WHO SAGE SAGE Geneva November 2013 Joseph Bresee, MD Epidemiology and Prevention Branch Influenza Division National Center for Immunization and Respiratory Diseases

More information

Planning and preparation for influenza pandemics are

Planning and preparation for influenza pandemics are Use of Influenza Risk Assessment Tool for Prepandemic Preparedness Stephen A. Burke, Susan C. Trock In 2010, the Centers for Disease Control and Prevention began to develop an Influenza Risk Assessment

More information

HPAI H5(N8) in Member States in poultry, captive and wild birds

HPAI H5(N8) in Member States in poultry, captive and wild birds HPAI H5(N8) in Member States in poultry, captive and wild birds (01/10/2016-01/03/2017) DG Health and Food Safety 13,578,000 5,610,000 234,000 Broad migration flows of ducks across Europe 1,000,000 71,000

More information

SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Regional Response

SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Regional Response SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Regional Response SARS Preparedness and Response Team World Health Organization Western Pacific Regional Office Western Pacific Region of WHO Jilin Ulaanbaatar

More information

Introduction to Avian Influenza

Introduction to Avian Influenza Introduction to Avian Influenza David L. Suarez D.V.M., Ph.D. Research Leader Exotic and Emerging Avian Viral Disease Research Unit Agricultural Research Service United States Department of Agriculture

More information

OFFLU STEERING AND EXECUTIVE COMMITTEE MEETING 31 March 2017 FAO Headquarters, Rome

OFFLU STEERING AND EXECUTIVE COMMITTEE MEETING 31 March 2017 FAO Headquarters, Rome OFFLU STEERING AND EXECUTIVE COMMITTEE MEETING 31 March 2017 FAO Headquarters, Rome Participants: Peter Daniels, Ian Brown, Billy Karesh, David Swayne, Giovanni Cattoli, Nicola Lewis, Gwenaelle Dauphin,

More information

AAHL s Regional One-Health Activities

AAHL s Regional One-Health Activities International partnerships Disease reservoirs Unique capability AAHL s Regional One-Health Activities Dr. Kurt Zuelke Director, Health & Biosecurity and AAHL 30 October 2015 6 th Asia Pacific Workshop

More information

Avian influenza - current situation and future trends

Avian influenza - current situation and future trends Avian influenza - current situation and future trends Calogero Terregino OIE, FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza, Istituto Zooprofilattico Sperimentale delle

More information

インフルエンザの疫学について 国 感染研インフルエンザウイルス研究センター WHOインフルエンザ協 センターセンター 切孝

インフルエンザの疫学について 国 感染研インフルエンザウイルス研究センター WHOインフルエンザ協 センターセンター 切孝 インフルエンザの疫学について 国 感染研インフルエンザウイルス研究センター WHOインフルエンザ協 センターセンター 切孝 1 Influenza A Viruses All influenza A virus subtypes are detected in aquatic birds H1 - H16 N1 - N9 Aquatic birds Poultry Humans Pigs Horses

More information

Update on influenza monitoring and vaccine development

Update on influenza monitoring and vaccine development Update on influenza monitoring and vaccine development Annette Fox WHO Collaborating Centre for Reference and Research on Influenza at The Peter Doherty Institute for Infection and Immunity 1 Outline Why

More information

Overview of human cases of AI H5N1 since 1997

Overview of human cases of AI H5N1 since 1997 Overview of human cases of AI H5N1 since 1997 Dr Sylvie Briand WHO Global Influenza Programme 7 October 2008 1 FAO-OIE- WHO Joint Technical Consultation on AI at the Human-Animal Interface Review of the

More information

Current Situation on Avian Influenza and the pandemic threat

Current Situation on Avian Influenza and the pandemic threat Vaccine-preventable diseases and Immunization, Communicable Diseases Surveillance and Response Current Situation on Avian Influenza and the pandemic threat IVth Joint EC/ECDC/WHO Workshop on Pandemic Influenza

More information

AI surveillance of domestic birds in Vietnam. Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia,

AI surveillance of domestic birds in Vietnam. Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia, AI surveillance of domestic birds in Vietnam Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia, 2008-2012 Kenji Sakurai, OIE Asia-Pacific Tokyo, 13-14 December 2012 Contents

More information

On 31 March 2013, the National Health and

On 31 March 2013, the National Health and Perspective Avian influenza A(H7N9) and the closure of live bird markets Manoj Murhekar, a Yuzo Arima, a Peter Horby, a Katelijn AH Vandemaele, b Sirenda Vong, c Feng Zijian, d Chin-Kei Lee, a Ailan Li

More information

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva Pandemic H1N1 2010 Dr. Maria Neira Global Influenza Programme WHO, Geneva WHO Role during pandemic (H1N1) 2009 Under the International Health Regulations (2005) Detect event (notification by Member States

More information

Identifying the Long-Term Effect of Prenatal Famine Exposure on Female Sterility (Extended Abstract)

Identifying the Long-Term Effect of Prenatal Famine Exposure on Female Sterility (Extended Abstract) PAA 2012 manuscript No. (will be inserted by the editor) Identifying the Long-Term Effect of Prenatal Famine Exposure on Female Sterility (Extended Abstract) Shige Song April 2, 2012 1 Introduction Female

More information

Recommended composition of influenza virus vaccines for use in the influenza season

Recommended composition of influenza virus vaccines for use in the influenza season Recommended composition of influenza virus vaccines for use in the 2006 2007 influenza season This recommendation relates to the composition of vaccines for the forthcoming influenza season in the northern

More information

Fare clic per modificare lo stile del titolo. Regional Perspective on HPAI

Fare clic per modificare lo stile del titolo. Regional Perspective on HPAI Regional Perspective on HPAI Emergency Center for Transboundary Animal Diseases Inception meeting of the OIE/JTF Project for Controlling Zoonoses in Asia under One Health Concept Tokyo, Japan, 19-20, December

More information

Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center

Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center Definitions: Epidemic The occurrence of cases of an illness in a community or region which

More information

Flu, Avian Flu and emerging aspects (H1N1 resistance)

Flu, Avian Flu and emerging aspects (H1N1 resistance) EU-CIS Seminar New trends in Infectious Diseases 26 28 November 2008 / Lyon, France Flu, Avian Flu and emerging aspects (H1N1 resistance) Pr. Florence MORFIN FRE 3011 Université Lyon 1 - CNRS Laboratory

More information

Significantly elevated number of human infections with H7N9 virus in Jiangsu in eastern China, October 2016 to January 2017

Significantly elevated number of human infections with H7N9 virus in Jiangsu in eastern China, October 2016 to January 2017 Research article Significantly elevated number of human infections with H7N9 virus in Jiangsu in eastern China, October 2016 to January 2017 Xiang Huo 1,2, Liling Chen 2,3, Xian Qi 1,2, Haodi Huang¹, Qigang

More information

Report from AI EURL on the developing situation with H5 HPAI

Report from AI EURL on the developing situation with H5 HPAI Report from AI EURL on the developing situation with H5 HPAI Andrew Breed and Ian Brown andrew.breed@apha.gsi.gov.uk PAFF Committee, section Animal Health and Welfare 4 th February 205, Brussels Recent

More information

Surveillance Overview

Surveillance Overview Number of Positive Specimens Percent Positive Number of Positive Specimens National Center for Immunization & Respiratory Diseases 2016-17 Surveillance Overview Lynnette Brammer, MPH Epidemiologist, Influenza

More information

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Masaya Kato, WHO Viet Nam OIE Regional Workshop on Enhancing Influenza A viruses National Surveillance

More information

Influenza: Seasonal, Avian, and Otherwise

Influenza: Seasonal, Avian, and Otherwise Influenza: Seasonal, Avian, and Otherwise Lisa Winston, MD University of California, San Francisco San Francisco General Hospital Influenza biology Antiviral medications Seasonal influenza Vaccination

More information

Control of Influenza A(H7N9) A HKU-China CDC Collaboration

Control of Influenza A(H7N9) A HKU-China CDC Collaboration Control of Influenza A(H7N9) A HKU-China CDC Collaboration Gabriel M Leung, Benjamin J Cowling, Joseph T Wu Public Health Research Centre The University of Hong Kong Li Ka Shing Faculty of Medicine October

More information

OIE tools and global overview on Avian Influenza Dr Jocelyn Mérot OIE Sub Regional Representation for North Africa Tunis, Tunisia

OIE tools and global overview on Avian Influenza Dr Jocelyn Mérot OIE Sub Regional Representation for North Africa Tunis, Tunisia 10 th JPC REMESA - Heraklion, Greece (16-17 March 2015) OIE tools and global overview on Avian Influenza Dr Jocelyn Mérot OIE Sub Regional Representation for North Africa Tunis, Tunisia 1 Global management

More information

Application of Reverse Genetics to Influenza Vaccine Development

Application of Reverse Genetics to Influenza Vaccine Development NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective

More information

Highly Pathogenic Avian Influenza Virus Research

Highly Pathogenic Avian Influenza Virus Research Highly Pathogenic Avian Influenza Virus Research Robert G. Webster, PhD Division of Virology Department of Infectious Diseases St. Jude Children s Research Hospital Memphis, TN Influenza A Viruses 15 HA

More information